RxDoctor Payments Data

Dirk Hentschel, MD

Nephrology · Boston, MANPI 1093771495

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,146 of the $51,718 with a category attached, or 64.1%. 11 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 29.1% of the total. Reporting peaked in 2019 at $25,950 and has fallen 94.1% since, to $1,540 in 2025. Among nephrology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,718in general payments, 2019–2025

Across 56 payments — averaging $923.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$15K
  • Merit Medical Systems Inc$15K
  • Laminate Medical Technologies Inc.$7K
  • Surmodics, Inc.$4K
  • Inari Medical, Inc.$3K
  • Avenu Medical Inc.$3K
  • plus $4K from 5 others
$102,357in research payments, 2019–2025

Across 5 payments — averaging $20,471 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merit Medical Systems Inc$90K
  • Medtronic$12K

What the payments were for

  • Consulting fees$33,14664%
  • Speaking & faculty fees$11,12022%
  • Travel & lodging$5,87511%
  • Food & beverage$1,5743%
  • Education$30%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,718 in reported general payments places this provider in the 90th percentile of 339 nephrology providers in Massachusetts.

See all nephrology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$291,218
Medicare patients
555
Services billed
2,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$53,303
Prednisone12$15

Paid to pharmacies, not to this prescriber.

Other nephrology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →